Schjøtt J - Search Results

1

Berg JA, Schjøtt J. Berg JA, et al. Among authors: schjott j. Tidsskr Nor Laegeforen. 2016 May 3;136(8):718-20. doi: 10.4045/tidsskr.15.0650. eCollection 2016 May. Tidsskr Nor Laegeforen. 2016. PMID: 27143462 Free article. Review. Norwegian. No abstract available.

2

Identifying target areas of medicines information efforts to pregnant and breastfeeding women by reviewing questions to SafeMotherMedicine: A Norwegian web-based public medicines information service.

Bakkebø T, Heitmann K, Vågsvoll K, Erdal H, Schjøtt J. Bakkebø T, et al. Among authors: schjott j. BMC Pregnancy Childbirth. 2022 Dec 2;22(1):893. doi: 10.1186/s12884-022-05252-3. BMC Pregnancy Childbirth. 2022. PMID: 36461026 Free PMC article.

3

A liposomal formulation of simvastatin and doxorubicin for improved cardioprotective and anti-cancer effect.

Bjørnstad R, Reiten IN, Knudsen KS, Schjøtt J, Herfindal L. Bjørnstad R, et al. Among authors: schjott j. Int J Pharm. 2022 Dec 15;629:122379. doi: 10.1016/j.ijpharm.2022.122379. Epub 2022 Nov 9. Int J Pharm. 2022. PMID: 36370997 Free article.

4

Answering questions from breastfeeding women on use of medications: which elements to include, and how to present them? A descriptive pilot study.

Bakkebø T, Heitmann K, Schjøtt J. Bakkebø T, et al. Among authors: schjott j. Int J Pharm Pract. 2023 Jun 30;31(4):442-443. doi: 10.1093/ijpp/riad029. Int J Pharm Pract. 2023. PMID: 37141392 No abstract available.

5

[Statins and muscular adverse effects].

Schjøtt J. Schjøtt J. Tidsskr Nor Laegeforen. 2000 Dec 10;120(30):3729-31. Tidsskr Nor Laegeforen. 2000. PMID: 11215947 Free article. Norwegian. No abstract available.

6

[Pregabalin and its potential for abuse].

Chalabianloo F, Schjøtt J. Chalabianloo F, et al. Among authors: schjott j. Tidsskr Nor Laegeforen. 2009 Jan 29;129(3):186-7. doi: 10.4045/tidsskr.08.0047. Tidsskr Nor Laegeforen. 2009. PMID: 19180163 Free article. Review. Norwegian.

7

[Handling of reactions to drug withdrawal].

Schjøtt J, Raknes G. Schjøtt J, et al. Tidsskr Nor Laegeforen. 2010 Jan 14;130(1):37-8. doi: 10.4045/tidsskr.09.1088. Tidsskr Nor Laegeforen. 2010. PMID: 20094122 Free article. Review. Norwegian.

8

Cross-reactivity of the CEDIA buprenorphine assay in drugs-of-abuse screening: influence of dose and metabolites of opioids.

Berg JA, Schjøtt J, Fossan KO, Riedel B. Berg JA, et al. Among authors: schjott j. Subst Abuse Rehabil. 2015 Oct 28;6:131-9. doi: 10.2147/SAR.S88935. eCollection 2015. Subst Abuse Rehabil. 2015. PMID: 26604854 Free PMC article.

9

Stability of Antidepressants and Antipsychotics in Gel Separator Tubes.

Berg JA, Schjøtt J, Carstensen K, Fossan KO, Skrede S, Bjånes TK, Serkland TT, Riedel B. Berg JA, et al. Among authors: schjott j. Ther Drug Monit. 2019 Apr;41(2):249-250. doi: 10.1097/FTD.0000000000000603. Ther Drug Monit. 2019. PMID: 30883518 No abstract available.

10

Distribution of Psychotropic Drugs Into Lipoproteins.

Serkland TT, Schjøtt J, Berg JA, Herfindal L, Riedel B, Skrede S. Serkland TT, et al. Among authors: schjott j. Ther Drug Monit. 2019 Dec;41(6):766-771. doi: 10.1097/FTD.0000000000000660. Ther Drug Monit. 2019. PMID: 31725695

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

113 results

Search Page